{"component": "definition", "props": {"groups": [{"samples": [{"hash": "gHoP3bqwTj6", "uri": "/contracts/gHoP3bqwTj6#second-tranche-note", "label": "Note Purchase Agreement (RVL Pharmaceuticals PLC)", "score": 33.6078033447, "published": true}, {"hash": "36pMGjmXVPy", "uri": "/contracts/36pMGjmXVPy#second-tranche-note", "label": "Note Purchase Agreement (Revance Therapeutics, Inc.)", "score": 33.3531837463, "published": true}, {"hash": "l4KPWlPr4X6", "uri": "/contracts/l4KPWlPr4X6#second-tranche-note", "label": "Note Purchase Agreement (Puma Biotechnology, Inc.)", "score": 32.8412055969, "published": true}], "snippet_links": [], "snippet": "has the meaning set forth in Section 2.01(b).", "size": 8, "hash": "aed10fbd68ab0dd98c2ae78d1e603601", "id": 1}, {"samples": [{"hash": "lNQFXQNZ8po", "uri": "/contracts/lNQFXQNZ8po#second-tranche-note", "label": "Securities Purchase Agreement (3 E Network Technology Group LTD)", "score": 36.4360046387, "published": true}, {"hash": "iPF4eDS0Uq1", "uri": "/contracts/iPF4eDS0Uq1#second-tranche-note", "label": "Securities Purchase Agreement (Zhibao Technology Inc.)", "score": 35.7268981934, "published": true}], "snippet_links": [{"key": "senior-secured-convertible-note", "type": "definition", "offset": [10, 41]}, {"key": "subject-to-the-terms", "type": "clause", "offset": [47, 67]}, {"key": "date-of-issuance", "type": "definition", "offset": [96, 112]}, {"key": "by-the-company", "type": "clause", "offset": [121, 135]}, {"key": "the-investor", "type": "definition", "offset": [139, 151]}, {"key": "form-of", "type": "definition", "offset": [170, 177]}, {"key": "exhibit-a", "type": "clause", "offset": [178, 187]}], "snippet": "means the Senior Secured Convertible Note due, subject to the terms therein, 12 months from the date of issuance, issued by the Company to the Investor hereunder, in the form of Exhibit A attached hereto.", "size": 6, "hash": "e2f12b721fafea9aa04abe0aa4f42105", "id": 2}, {"samples": [{"hash": "88aX9rEsmfL", "uri": "/contracts/88aX9rEsmfL#second-tranche-note", "label": "Securities Purchase Agreement (Healthcare Triangle, Inc.)", "score": 35.0013694763, "published": true}, {"hash": "aSNmkqoJbh9", "uri": "/contracts/aSNmkqoJbh9#second-tranche-note", "label": "Securities Purchase Agreement", "score": 34.78647995, "published": true}, {"hash": "5iJBBg4DV9T", "uri": "http://pdf.secdatabase.com/1537/0001607062-24-000003.pdf", "label": "pdf.secdatabase.com", "score": 20.2263717651, "published": false}], "snippet_links": [{"key": "senior-secured-convertible-note", "type": "definition", "offset": [10, 41]}, {"key": "subject-to-the-terms", "type": "clause", "offset": [47, 67]}, {"key": "date-of-issuance", "type": "definition", "offset": [96, 112]}, {"key": "by-the-company", "type": "clause", "offset": [121, 135]}, {"key": "the-investor", "type": "definition", "offset": [139, 151]}, {"key": "form-of", "type": "definition", "offset": [170, 177]}, {"key": "exhibit-a", "type": "clause", "offset": [178, 187]}], "snippet": "means the Senior Secured Convertible Note due, subject to the terms therein, 18 months from the date of issuance, issued by the Company to the Investor hereunder, in the form of Exhibit A attached hereto.", "size": 3, "hash": "7a29aa1618b3d8ce6663025ef5989150", "id": 3}, {"samples": [{"hash": "9o1u9tVbAXV", "uri": "/contracts/9o1u9tVbAXV#second-tranche-note", "label": "Convertible Loan Note Purchase Agreement (Immunocore LTD)", "score": 32.0390129089, "published": true}, {"hash": "em7ARdsYg9w", "uri": "/contracts/em7ARdsYg9w#second-tranche-note", "label": "Convertible Loan Note Purchase Agreement (Immunocore LTD)", "score": 31.9733066559, "published": true}], "snippet_links": [{"key": "convertible-loan-note", "type": "definition", "offset": [10, 31]}, {"key": "set-out", "type": "definition", "offset": [44, 51]}, {"key": "exhibit-b", "type": "clause", "offset": [55, 64]}, {"key": "by-the-company", "type": "clause", "offset": [78, 92]}, {"key": "the-second-closing", "type": "definition", "offset": [96, 114]}], "snippet": "means the convertible loan note in the form set out in Exhibit B to be issued by the Company on the Second Closing;", "size": 2, "hash": "a16f8cd70e81cf091c79a216380e7526", "id": 4}, {"samples": [{"hash": "ckTySwKp4tQ", "uri": "/contracts/ckTySwKp4tQ#second-tranche-note", "label": "Twentieth Supplemental Indenture (Metlife Inc)", "score": 21.8350448608, "published": true}], "snippet_links": [{"key": "of-the-company", "type": "clause", "offset": [13, 27]}, {"key": "the-base-indenture", "type": "clause", "offset": [61, 79]}, {"key": "other-terms", "type": "definition", "offset": [128, 139]}, {"key": "designation-of", "type": "clause", "offset": [171, 185]}, {"key": "the-phrase", "type": "clause", "offset": [206, 216]}, {"key": "series-c", "type": "clause", "offset": [218, 226]}, {"key": "tranche-2", "type": "definition", "offset": [256, 265]}], "snippet": "means a Note of the Company that shall be issued pursuant to the Base Indenture as provided in Section 2.10 and shall have such other terms set forth in Section 2.10, the designation of which Note shall be the phrase \u201cSeries C Senior Component Debentures, Tranche 2, due 2023\u201d.", "size": 2, "hash": "fb7c5c2a9613a9082e4856cd98666d3d", "id": 5}, {"samples": [{"hash": "4E2ceqMMZfe", "uri": "/contracts/4E2ceqMMZfe#second-tranche-note", "label": "Credit Facilities Agreement (Antares Pharma Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "the-promissory-note", "type": "clause", "offset": [6, 25]}, {"key": "of-the-borrower", "type": "clause", "offset": [26, 41]}, {"key": "by-the-borrower", "type": "clause", "offset": [101, 116]}, {"key": "the-agent", "type": "clause", "offset": [120, 129]}, {"key": "on-behalf-of", "type": "clause", "offset": [130, 142]}, {"key": "second-funding-date", "type": "definition", "offset": [162, 181]}, {"key": "the-advance", "type": "clause", "offset": [197, 208]}, {"key": "the-second-tranche", "type": "clause", "offset": [212, 230]}, {"key": "by-the-lenders", "type": "clause", "offset": [231, 245]}, {"key": "to-the-borrower", "type": "definition", "offset": [246, 261]}], "snippet": "means the promissory note of the Borrower substantially in the form set forth in Schedule \u201cE\u201d issued by the Borrower to the Agent on behalf of the Lenders at the Second Funding Date and evidencing the advance of the Second Tranche by the Lenders to the Borrower.", "size": 1, "hash": "db0712f8df8079e7c3c1ac4680000ea6", "id": 6}, {"samples": [{"hash": "6XJWnZnXT9o", "uri": "/contracts/6XJWnZnXT9o#second-tranche-note", "label": "Note Purchase Agreement (Revance Therapeutics, Inc.)", "score": 32.8507881165, "published": true}], "snippet_links": [{"key": "second-tranche-note-purchase-commitment", "type": "definition", "offset": [47, 86]}, {"key": "aggregate-principal-amount", "type": "definition", "offset": [138, 164]}, {"key": "the-second-tranche", "type": "clause", "offset": [168, 186]}, {"key": "purchase-commitments", "type": "definition", "offset": [192, 212]}], "snippet": "has the meaning set forth in Section 2.01(b). \u201cSecond Tranche Note Purchase Commitment\u201d has the meaning set forth in Section 2.01(b). The aggregate principal amount of the Second Tranche Note Purchase Commitments of all of the Second", "size": 1, "hash": "7fa347e608a2012280b95177c8501f39", "id": 7}, {"samples": [{"hash": "ldbMvYkFD4U", "uri": "/contracts/ldbMvYkFD4U#second-tranche-note", "label": "Securities Purchase Agreement (Photomedex Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "convertible-promissory-note", "type": "clause", "offset": [8, 35]}, {"key": "of-the-company", "type": "clause", "offset": [36, 50]}, {"key": "exhibit-a", "type": "clause", "offset": [97, 106]}, {"key": "aggregate-principal-amount", "type": "definition", "offset": [118, 144]}, {"key": "equal-to", "type": "definition", "offset": [145, 153]}, {"key": "the-second-tranche", "type": "clause", "offset": [154, 172]}, {"key": "note-amount", "type": "clause", "offset": [173, 184]}, {"key": "initial-conversion-price", "type": "definition", "offset": [192, 216]}, {"key": "second-tranche-conversion-price", "type": "definition", "offset": [230, 261]}], "snippet": "means a convertible promissory note of the Company, substantially in the form attached hereto as Exhibit A, having an aggregate principal amount equal to the Second Tranche Note Amount and an initial conversion price equal to the Second Tranche Conversion Price.", "size": 1, "hash": "9a985f79b1dc9cc3ce216d3d893c562b", "id": 8}, {"samples": [{"hash": "fA2y7Zve6EX", "uri": "/contracts/fA2y7Zve6EX#second-tranche-note", "label": "Securities Purchase Agreement (Newcourt Acquisition Corp)", "score": 35.0396995544, "published": true}], "snippet_links": [{"key": "second-tranche-closing", "type": "definition", "offset": [59, 81]}], "snippet": "means up to $3,125,000 in principal Note issuable upon the Second Tranche Closing.", "size": 1, "hash": "6da26e4f4929ba6b1a15571fd3eb93a4", "id": 9}, {"samples": [{"hash": "g6Q0yOImLtm", "uri": "/contracts/g6Q0yOImLtm#second-tranche-note", "label": "Securities Purchase Agreement (Zeta Network Group)", "score": 37.1943855286, "published": true}], "snippet_links": [{"key": "note-to", "type": "clause", "offset": [37, 44]}, {"key": "by-the-company", "type": "clause", "offset": [55, 69]}, {"key": "the-investor", "type": "definition", "offset": [73, 85]}, {"key": "second-tranche-closing", "type": "definition", "offset": [103, 125]}, {"key": "form-of", "type": "definition", "offset": [133, 140]}, {"key": "exhibit-a", "type": "clause", "offset": [141, 150]}], "snippet": "means the Senior Secured Convertible Note to be issued by the Company to the Investor hereunder in the Second Tranche Closing in the form of Exhibit A attached hereto.", "size": 1, "hash": "3be0ebce40ac16e0ec909d465716e282", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIcc2Vjb25kLXRyYW5jaGUtbm90ZSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Second Tranche Note", "snippet": "has the meaning set forth in Section 2.01(b).", "size": 27, "id": "second-tranche-note", "examples": ["The Closing shall occur remotely via the exchange of documents and signatures on or prior to the Closing Date, promptly following the satisfaction of all conditions for Closing set forth below and all conditions necessary to consummate the issuance of the <strong>Second Tranche Note</strong> (as defined in the Amended Note Purchase Agreement) pursuant to the Amended Note Purchase Agreement.", "The <strong>Second Tranche Notes</strong> Issuance shall consist of <strong>Second Tranche Notes</strong> simultaneously issued by the Issuer to each of the Second Tranche Purchasers in accordance with their respective <strong>Second Tranche Note</strong> Purchase Commitments.", "The Closing shall occur simultaneously with the issuance of the <strong>Second Tranche Note</strong>.", "The <strong>Second Tranche Note</strong> Purchase Commitments will be automatically and permanently reduced to zero upon the <strong>Second Tranche Notes</strong> Issuance pursuant to Section 2.01(b).", "The purchase price for the <strong>Second Tranche Note</strong> to be purchased by the Buyer at the Second Tranche Closing (the \u201cSecond Tranche Purchase Price\u201d) shall be $1,350,000.", "Upon any termination of the <strong>Second Tranche Note</strong> Purchase Commitments, the <strong>Second Tranche Note</strong> Purchase Commitments of each Appropriate Purchaser shall be reduced by such Purchaser\u2019s Applicable Percentage of such reduction amount.", "On the Second Tranche Closing Date, subject to mutual consent, provided that the Equity Conditions shall be satisfied as of such date and upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Investor agrees to purchase $1,000,000 of Principal Amount of the <strong>Second Tranche Note</strong> and the number of Warrants as determined pursuant to Section 2.2(a).", "The Investor shall deliver to the Company, via wire transfer, immediately available funds equal to the Investor\u2019s Subscription Amount as to the Second Tranche Closing as set forth on the signature page hereto executed by the Investor, and the Company shall deliver to the Investor the <strong>Second Tranche Note</strong> and the Warrants, and the Company and the Investor shall deliver the other items set forth in Section 2.2 at the Second Tranche Closing.", "The Investor shall deliver to the Company, via wire transfer, immediately available funds equal to the Investor\u2019s Subscription Amount as to the Second Tranche Closing as set forth on the signature page hereto executed by the Investor, and the Company shall deliver to the Investor the <strong>Second Tranche Note</strong> and a Warrants, as determined pursuant to Section 2.2(a), and the Company and the Investor shall deliver the other items set forth in Section 2.2 deliverable at the Second Tranche Closing.", "The Issuer may, upon written notice to the Administrative Agent during the Second Tranche Availability Period, terminate in full the <strong>Second Tranche Note</strong> Purchase Commitments; provided, that: any such notice shall be received by the Administrative Agent not later than 9:00 a.m. five (5) Business Days prior to the date of termination."], "related": [["second-tranche", "Second Tranche", "Second Tranche"], ["bridge-note", "Bridge Note", "Bridge Note"], ["revolving-note", "Revolving Note", "Revolving Note"], ["revolving-notes", "Revolving Notes", "Revolving Notes"], ["tranche-b-note", "Tranche B Note", "Tranche B Note"]], "related_snippets": [], "updated": "2026-06-15T06:02:09+00:00"}, "json": true, "cursor": ""}}